Does Saxenda really make you 'naturally eat less'?

What did @sophisticatedmama actually say?

She lost seven pounds in her first week on Saxenda (liraglutide), starting at 0.6 mg daily, without counting calories or going to the gym. She says she feels "less hungry" and that she prepares food but "won't finish it" because she feels full sooner. She also mentions dose escalation happening weekly, up to what she calls "three milliliters." These are the core claims: rapid early weight loss, reduced appetite, early satiety, and a dose titration schedule.

One thing worth flagging immediately: she says the dose goes from 0.6 to 3 milliliters. Saxenda is dosed in milligrams, not milliliters. The pen delivers liraglutide in a concentration of 6 mg/mL. The final maintenance dose is 3 mg per day, which is 0.5 mL of solution. This is a units confusion, not a safety issue here, but it is the kind of imprecise language that spreads on TikTok and causes real misunderstandings for people self-dosing or comparing prescriptions.

Does the science back this up?

The appetite suppression and early satiety she describes are well-documented and real. The seven-pound first-week loss is plausible but almost certainly not all fat. Here is where the science gets important to understand.

GLP-1 receptor agonists like liraglutide work by slowing gastric emptying, reducing appetite signaling in the hypothalamus, and increasing feelings of fullness after eating. Pi-Sunyer et al. (2015, NEJM) found that patients on 3 mg liraglutide lost an average of 8.4 kg over 56 weeks versus 2.8 kg on placebo. That is meaningful, but it is a weekly average of about 0.15 kg. Seven pounds in one week is well above that pace.

The most likely explanation for early rapid loss: glycogen depletion and water weight. When you eat significantly less, your body burns through glycogen stores first. Each gram of glycogen holds roughly 3-4 grams of water. Reducing intake sharply can drop 3-5 pounds of water weight in days. This is real weight on the scale, but it is not the same as fat loss, and it will not continue at that pace.

What did they get wrong (or right)?

She got the mechanism basically right. "I feel less hungry" and eating less without trying are exactly what liraglutide is designed to do. That is not placebo. Wilding et al. (2021, NEJM), while studying semaglutide rather than liraglutide, confirmed that GLP-1 agonists produce meaningful reductions in caloric intake through appetite and satiety pathways. Liraglutide has its own robust trial data confirming the same mechanism.

What she got wrong, or at least imprecisely right, is the dose unit (milligrams versus milliliters) and the implicit framing that seven pounds in a week is representative of what Saxenda does. It is not. That number will almost certainly not repeat in week two. Studies consistently show that initial rapid loss slows significantly after the first two to four weeks as water weight stabilizes and the body adjusts.

She also does not mention common side effects at all. Nausea affects roughly 40% of patients starting liraglutide (Davies et al., 2015, Lancet Diabetes and Endocrinology). Someone watching this and not experiencing those results might think they are doing something wrong, when in fact the medication works differently for everyone.

What should you actually know?

If you are watching this and thinking Saxenda will drop seven pounds your first week, reset that expectation now. Clinical trial averages are not week-one numbers. The SCALE Obesity and Prediabetes trial showed roughly 8% body weight loss over 56 weeks. That is meaningful, but it is slow and it requires staying on the medication.

A few things this video does not cover that matter: Saxenda requires a legitimate prescription and medical evaluation. It is not appropriate for everyone, including people with a personal or family history of medullary thyroid carcinoma. The dose escalation schedule she describes exists specifically to reduce gastrointestinal side effects, not just for general safety theater. Skipping that schedule or trying to accelerate it is how people end up stopping the medication entirely because of nausea.

Also worth saying plainly: liraglutide and semaglutide are related but not the same drug. Saxenda and Ozempic or Wegovy are not interchangeable, and compounded versions of any GLP-1 are not equivalent to FDA-approved brand-name medications. If you are considering any of these medications, talk to a licensed provider, not a TikTok comment section.